S-Adenosyl Methionine
•Last Updated: September 28 2022
S-Adenosylmethionine (SAMe) is a methyl donating compound that circulates in the blood and provides methyl groups to maintain other metabolic reactions. Lowered SAMe levels are associated with depressive symptoms, and supplementation may aid a partial deficiency.
S-Adenosyl Methionine is most often used for
Last Updated: September 28 2022
S-Adenosyl Methionine (SAMe) is the amino acid methionine bound to an ATP molecule; this molecule circulates in the blood naturally and acts as a 'methyl donor'. A methyl group in chemistry is simply a carbon molecule (bound to some hydrogens), and donating a methyl group to other molecules can accelerate or preserve reactions in the body as a form of metabolic 'maintenance'. Choline is another prominent methyl donor in the body, but due to selectivity of some reactions the two are not necessarily interchangeable.
Some body states appear to be associated with lower circulating levels of SAMe, including osteoarthritis and depression where SAMe appears to hold potent therapeutic potential; after a build-up period of 1-2 months, supplemental SAMe at 800-1600mg daily appears to be as potent as some pharmaceutical options for both osteoarthritis and depression and appears to enhance some anti-depressants. Although lower circulating levels of SAMe are also seen in diabetes, the benefits of SAMe and glucose control are not as well established as depression and osteoarthritis.
SAMe appears to follow many nutrient-like motifs in the body, being regulated within a certain serum range and being associated with adverse effects when that range is perturbed. It potentially holds a lot of benefit in body states where circulating SAMe levels decline.
Although side-effects are not commonly reported with SAMe, numerous studies note a small set of participants who experience mania after supplementing SAMe. It is not common, but it does appear to be related to SAMe supplementation for unknown reasons; it has been reported in some persons without history of mania as well and does not appear to be related to any pathological condition per se.
Note that S-Adenosyl Methionine is also known as:
- SAME
- SAMe
- Ademethionine
- S-adenosyl-L-methionine
- Adomet
S-Adenosyl Methionine should not be confused with:
- Methionine (the isolated amino acid)
Supplementation of S-adenosylmethionine tends to be in the 600-1,200mg range over the course of a day, divided into two or three separated doses with meals. The higher dosage (1,200mg) tends to be used more often, with the lower dosage (600mg) being used to cut costs.
For S-adenosylmethionine to benefit osteoarthritis, it appears to require a few weeks or up to a month of continual usage for benefits to show. Benefits to depressive symptoms may be much more rapid.
Research FeedRead all studies
1.^S-Adenosylmethionine (Ademetionine) in Psychiatric Disorders: Historical Perspective and Current Status.()
2.^Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EHHomocysteine, folate, methylation, and monoamine metabolism in depressionJ Neurol Neurosurg Psychiatry.(2000 Aug)
3.^Loehrer FM, Schwab R, Angst CP, Haefeli WE, Fowler BInfluence of oral S-adenosylmethionine on plasma 5-methyltetrahydrofolate, S-adenosylhomocysteine, homocysteine and methionine in healthy humansJ Pharmacol Exp Ther.(1997 Aug)
4.^Thompson MA, Bauer BA, Loehrer LL, Cha SS, Mandrekar JN, Sood A, Wahner-Roedler DLDietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trialJ Altern Complement Med.(2009 May)
5.^Struys EA, Jansen EE, de Meer K, Jakobs CDetermination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometryClin Chem.(2000 Oct)
6.^Bell KM, Potkin SG, Carreon D, Plon LS-adenosylmethionine blood levels in major depression: changes with drug treatmentActa Neurol Scand Suppl.(1994)
7.^Shippy RA, Mendez D, Jones K, Cergnul I, Karpiak SES-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDSBMC Psychiatry.(2004 Nov 11)
8.^S-Adenosylmethionine Levels in the Diagnosis of Pneumocystis carinii Pneumonia in Patients with HIV Infection.()
9.^Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EHCerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionineJ Neurol Neurosurg Psychiatry.(1990 Dec)
10.^Poirier LA, Brown AT, Fink LM, Wise CK, Randolph CJ, Delongchamp RR, Fonseca VABlood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathyMetabolism.(2001 Sep)
11.^Maj M, Zizolfi S, Del Vecchio MBlood levels of S-adenosylmethionine in unmedicated schizophrenic and depressive patientsNeuropsychobiology.(1981)
12.^Andreoli VM, Maffei F, Tonon GCS-adenosyl-L-methionine (SAMe) blood levels in schizophrenia and depressionMonogr Gesamtgeb Psychiatr Psychiatry Ser.(1978)
13.^Strous RD, Ritsner MS, Adler S, Ratner Y, Maayan R, Kotler M, Lachman H, Weizman AImprovement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophreniaEur Neuropsychopharmacol.(2009 Jan)
14.^Stabler SP, Allen RH, Dolce ET, Johnson MAElevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatmentAm J Clin Nutr.(2006 Dec)
15.^Poirier LA, Wise CK, Delongchamp RR, Sinha RBlood determinations of S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine: correlations with dietCancer Epidemiol Biomarkers Prev.(2001 Jun)
16.^Stramentinoli GPharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamicsAm J Med.(1987 Nov 20)
17.^Silveri MM, Parow AM, Villafuerte RA, Damico KE, Goren J, Stoll AL, Cohen BM, Renshaw PFS-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjectsBiol Psychiatry.(2003 Oct 15)
18.^Dunne JB, Alexander B, Williams R, Tredger JMEvidence that S-adenosyl-L-methionine diastereoisomers may reduce ischaemia-reperfusion injury by interacting with purinoceptors in isolated rat liverBr J Pharmacol.(1998 Sep)
19.^Hoffman JLChromatographic analysis of the chiral and covalent instability of S-adenosyl-L-methionineBiochemistry.(1986 Jul 29)
20.^Lee S, Floss HG, Gilbert BA, Rando RRSteric Course of the Methyl Transfer from AdoMet to S-Farnesyl-3-thiopropionate by G-Protein MethyltransferaseJ Org Chem.(1998 Feb 6)
21.^Kealey JT, Lee S, Floss HG, Santi DVStereochemistry of methyl transfer catalyzed by tRNA (m5U54)-methyltransferase--evidence for a single displacement mechanismNucleic Acids Res.(1991 Dec 11)
22.^Woodard RW, Tsai MD, Floss HG, Crooks PA, Coward JKStereochemical course of the transmethylation catalyzed by catechol O-methyltransferaseJ Biol Chem.(1980 Oct 10)
23.^Borchardt RT, Wu YSPotential inhibitors of S-adenosylmethionine-dependent methyltransferases. 5. Role of the asymmetric sulfonium pole in the enzymatic binding of S-adenosyl-L-methionineJ Med Chem.(1976 Sep)
24.^Najm WI, Reinsch S, Hoehler F, Tobis JS, Harvey PWS-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. {ISRCTN36233495}BMC Musculoskelet Disord.(2004 Feb 26)
25.^McMillan JM, Walle UK, Walle TS-adenosyl-L-methionine: transcellular transport and uptake by Caco-2 cells and hepatocytesJ Pharm Pharmacol.(2005 May)
26.^Yang J, He Y, Du YX, Tang LL, Wang GJ, Fawcett JPPharmacokinetic properties of S-adenosylmethionine after oral and intravenous administration of its tosylate disulfate salt: a multiple-dose, open-label, parallel-group study in healthy Chinese volunteersClin Ther.(2009 Feb)
27.^Giulidori P, Cortellaro M, Moreo G, Stramentinoli GPharmacokinetics of S-adenosyl-L-methionine in healthy volunteersEur J Clin Pharmacol.(1984)
28.^Agrimi G, Di Noia MA, Marobbio CM, Fiermonte G, Lasorsa FM, Palmieri FIdentification of the human mitochondrial S-adenosylmethionine transporter: bacterial expression, reconstitution, functional characterization and tissue distributionBiochem J.(2004 Apr 1)
29.^Dridi L, Ahmed Ouameur A, Ouellette MHigh affinity S-Adenosylmethionine plasma membrane transporter of Leishmania is a member of the folate biopterin transporter (FBT) familyJ Biol Chem.(2010 Jun 25)
30.^Horne DW, Holloway RS, Wagner CTransport of S-adenosylmethionine in isolated rat liver mitochondriaArch Biochem Biophys.(1997 Jul 15)
31.^Williams AC, Ramsden DBNicotinamide homeostasis: a xenobiotic pathway that is key to development and degenerative diseasesMed Hypotheses.(2005)
32.^Pavia J, Martos F, Gonzalez-Correa JA, Garcia AJ, Rius F, Laukkonen S, de la Cuesta FSEffect of S-adenosyl methionine on muscarinic receptors in young ratsLife Sci.(1997)
33.^Muccioli G, Scordamaglia A, Bertacco S, Di Carlo REffect of S-adenosyl-L-methionine on brain muscarinic receptors of aged ratsEur J Pharmacol.(1992 Nov 2)
34.^Chan A, Tchantchou F, Graves V, Rozen R, Shea TBDietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: critical role of S-adenosyl methionineJ Nutr Health Aging.(2008 Apr)
35.^Shea TB, Chan AS-adenosyl methionine: a natural therapeutic agent effective against multiple hallmarks and risk factors associated with Alzheimer's diseaseJ Alzheimers Dis.(2008 Feb)
36.^Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri TFolate, vitamin B12, and homocysteine in major depressive disorderAm J Psychiatry.(1997 Mar)
37.^Alpert JE, Mischoulon D, Nierenberg AA, Fava MNutrition and depression: focus on folateNutrition.(2000 Jul-Aug)
38.^Bottiglieri T, Chary TK, Laundy M, Carney MW, Godfrey P, Toone BK, Reynolds EHTransmethylation in depressionAla J Med Sci.(1988 Jul)
39.^Matthysse S, Baldessarini RJS-adenosylmethionine and catechol-O-methyl-transferase in schizophreniaAm J Psychiatry.(1972 Apr)
40.^Tolbert LCMAT kinetics in affective disorders and schizophrenia. An accountAla J Med Sci.(1988 Jul)
41.^Bressa GMS-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studiesActa Neurol Scand Suppl.(1994)
42.^Saletu-Zyhlarz GM, Anderer P, Linzmayer L, Semlitsch HV, Assandri A, Prause W, Hassan Abu-Bakr M, Lindeck-Pozza E, Saletu BVisualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mappingInt J Neuropsychopharmacol.(2002 Sep)
44.^Fava M, Giannelli A, Rapisarda V, Patralia A, Guaraldi GPRapidity of onset of the antidepressant effect of parenteral S-adenosyl-L-methioninePsychiatry Res.(1995 Apr 28)
45.^Berlanga C, Ortega-Soto HA, Ontiveros M, Senties HEfficacy of S-adenosyl-L-methionine in speeding the onset of action of imipraminePsychiatry Res.(1992 Dec)
46.^Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava MS-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trialAm J Psychiatry.(2010 Aug)
47.^Fleisch SB, Travis MJ, Ryan NDDiscrepancy in response and remission rates for SAMe-treated patients in a double-blind, randomized clinical trialAm J Psychiatry.(2010 Dec)
48.^Alpert JE, Papakostas G, Mischoulon D, Worthington JJ 3rd, Petersen T, Mahal Y, Burns A,Bottiglieri T, Nierenberg AA, Fava MS-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxineJ Clin Psychopharmacol.(2004 Dec)
49.^Sarris J1, I Papakostas G2, Vitolo O2, Fava M2, Mischoulon D2S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of responseJ Affect Disord.(2014 Aug)
50.^Strous RD, Nolan KA, Lapidus R, Diaz L, Saito T, Lachman HMAggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication studyAm J Med Genet B Neuropsychiatr Genet.(2003 Jul 1)
51.^Strous RD, Bark N, Parsia SS, Volavka J, Lachman HMAnalysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behaviorPsychiatry Res.(1997 Mar 24)
52.^Di Rocco A, Rogers JD, Brown R, Werner P, Bottiglieri TS-Adenosyl-Methionine improves depression in patients with Parkinson's disease in an open-label clinical trialMov Disord.(2000 Nov)
53.^Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GIEffects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorderJ Affect Disord.(2012 Feb)
54.^Arnold O, Saletu B, Anderer P, Assandri A, di Padova C, Corrado M, Saletu-Zyhlarz GMDouble-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometryEur Neuropsychopharmacol.(2005 Oct)
55.^Spijkerman AM, Smulders YM, Kostense PJ, Henry RM, Becker A, Teerlink T, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDS-adenosylmethionine and 5-methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine: the Hoorn StudyArterioscler Thromb Vasc Biol.(2005 Apr)
56.^Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease.()
57.^Mischoulon D, Alpert JE, Arning E, Bottiglieri T, Fava M, Papakostas GIBioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorderJ Clin Psychiatry.(2012 Jun)
58.^Gören JL, Stoll AL, Damico KE, Sarmiento IA, Cohen BMBioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humansPharmacotherapy.(2004 Nov)
59.^Tavoni A, Vitali C, Bombardieri S, Pasero GEvaluation of S-adenosylmethionine in primary fibromyalgia. A double-blind crossover studyAm J Med.(1987 Nov 20)
60.^Volkmann H, Nørregaard J, Jacobsen S, Danneskiold-Samsøe B, Knoke G, Nehrdich DDouble-blind, placebo-controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with fibromyalgiaScand J Rheumatol.(1997)
61.^Jacobsen S, Danneskiold-Samsøe B, Andersen RBOral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluationScand J Rheumatol.(1991)
62.^Goldenberg DLPharmacological treatment of fibromyalgia and other chronic musculoskeletal painBest Pract Res Clin Rheumatol.(2007 Jun)
63.^Kalhan SC, Edmison J, Marczewski S, Dasarathy S, Gruca LL, Bennett C, Duenas C, Lopez RMethionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionineClin Sci (Lond).(2011 Aug)
64.^Loguercio C, Nardi G, Argenzio F, Aurilio C, Petrone E, Grella A, Del Vecchio Blanco C, Coltorti MEffect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver diseaseAlcohol Alcohol.(1994 Sep)
65.^Chawla RK, Lewis FW, Kutner MH, Bate DM, Roy RG, Rudman DPlasma cysteine, cystine, and glutathione in cirrhosisGastroenterology.(1984 Oct)
66.^Yuan L, Kaplowitz NGlutathione in liver diseases and hepatotoxicityMol Aspects Med.(2009 Feb-Apr)
67.^Mato JM, Cámara J, Fernández de Paz J, Caballería L, Coll S, Caballero A, García-Buey L, Beltrán J, Benita V, Caballería J, Solà R, Moreno-Otero R, Barrao F, Martín-Duce A, Correa JA, Parés A, Barrao E, García-Magaz I, Puerta JL, Moreno J, Boissard G, Ortiz P, Rodés JS-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trialJ Hepatol.(1999 Jun)
68.^Santini D, Vincenzi B, Massacesi C, Picardi A, Gentilucci UV, Esposito V, Liuzzi G, La Cesa A, Rocci L, Marcucci F, Montesarchio V, Groeger AM, Bonsignori M, Tonini GS-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injuryAnticancer Res.(2003 Nov-Dec)
69.^Binder T, Salaj P, Zima T, Vítek LRandomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancyJ Perinat Med.(2006)
70.^Roncaglia N, Locatelli A, Arreghini A, Assi F, Cameroni I, Pezzullo JC, Ghidini AA randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasisBJOG.(2004 Jan)
71.^Nicastri PL, Diaferia A, Tartagni M, Loizzi P, Fanelli MA randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancyBr J Obstet Gynaecol.(1998 Nov)
72.^Floreani A, Paternoster D, Melis A, Grella PVS-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trialEur J Obstet Gynecol Reprod Biol.(1996 Aug)
73.^Ribalta J, Reyes H, Gonzalez MC, Iglesias J, Arrese M, Poniachik J, Molina C, Segovia NS-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative resultsHepatology.(1991 Jun)
74.^Duong FH, Christen V, Filipowicz M, Heim MHS-Adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitroHepatology.(2006 Apr)
75.^Duong FH, Filipowicz M, Tripodi M, La Monica N, Heim MHHepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2AGastroenterology.(2004 Jan)
76.^Duong FH, Christen V, Berke JM, Penna SH, Moradpour D, Heim MHUpregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1J Virol.(2005 Dec)
77.^Filipowicz M, Bernsmeier C, Terracciano L, Duong FH, Heim MHS-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponsePLoS One.(2010 Nov 8)
78.^Feld JJ, Modi AA, El-Diwany R, Rotman Y, Thomas E, Ahlenstiel G, Titerence R, Koh C, Cherepanov V, Heller T, Ghany MG, Park Y, Hoofnagle JH, Liang TJS-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonrespondersGastroenterology.(2011 Mar)
79.^Medici V, Virata MC, Peerson JM, Stabler SP, French SW, Gregory JF 3rd, Albanese A, Bowlus CL, Devaraj S, Panacek EA, Richards JR, Halsted CHS-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trialAlcohol Clin Exp Res.(2011 Nov)
80.^Caruso I, Pietrogrande VItalian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint diseaseAm J Med.(1987 Nov 20)
81.^Witte S, Lasek R, Victor NMeta-analysis of the efficacy of adenosylmethionine and oxaceprol in the treatment of osteoarthritisOrthopade.(2002 Nov)
82.^Soeken KL, Lee WL, Bausell RB, Agelli M, Berman BMSafety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritisJ Fam Pract.(2002 May)
83.^di Padova CS-adenosylmethionine in the treatment of osteoarthritis. Review of the clinical studiesAm J Med.(1987 Nov 20)
84.^Kim J, Lee EY, Koh EM, Cha HS, Yoo B, Lee CK, Lee YJ, Ryu H, Lee KH, Song YWComparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: an 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patientsClin Ther.(2009 Dec)
85.^Papadopoulos V, Kamtchouing P, Drosdowsky MA, Carreau SEffects of the transmethylation inhibitor S-adenosyl-homocysteine and of the methyl donor S-adenosyl-methionine on rat Leydig cell function in vitroJ Steroid Biochem.(1987 Jan)
86.^Manteuffel-Cymborowska M, Chmurzynska W, Grzelakowska-Sztabert BTissue-specific effects of testosterone on S-adenosylmethionine formation and utilization in the mouseBiochim Biophys Acta.(1992 Apr 22)
87.^Heljasvaara R, Veress I, Halmekytö M, Alhonen L, Jänne J, Laajala P, Pajunen ATransgenic mice overexpressing ornithine and S-adenosylmethionine decarboxylases maintain a physiological polyamine homoeostasis in their tissuesBiochem J.(1997 Apr 15)
88.^Crozat A, Palvimo JJ, Julkunen M, Jänne OAComparison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organsEndocrinology.(1992 Mar)
89.^Fjösne HE, Strand H, Sunde ADose-dependent induction of ornithine decarboxylase and S-adenosyl-methionine decarboxylase activity by testosterone in the accessory sex organs of male ratsProstate.(1992)
90.^de las Heras MA, Calandra RSS-adenosyl-L-methionine decarboxylase activity in the rat epididymis: ontogeny and androgenic controlJ Androl.(1991 May-Jun)
91.^Müller T, Fowler B, Kuhn WLevodopa intake increases plasma levels of S-adenosylmethionine in treated patients with Parkinson diseaseClin Neuropharmacol.(2005 Nov-Dec)
92.^Kagan BL, Sultzer DL, Rosenlicht N, Gerner RHOral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trialAm J Psychiatry.(1990 May)
93.^A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia.()